MIM
GH icon

Monashee Investment Management’s Guardant Health GH Stock Holding History

Monashee Investment Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-37,000
Closed -$1.32M – 83
2023
Q2 		$1.32M Buy
+37,000
New +$1.06M 0.32% 49
2021
Q3 		– Sell
-60,000
Closed -$7.45M – 310
2021
Q2 		$7.45M Buy
+60,000
New +$8.07M 0.89% 14
2021
Q1 		– Sell
-35,000
Closed -$4.51M – 395
2020
Q4 		$4.51M Buy
+35,000
New +$4.03M 0.6% 31
2020
Q3 		– Sell
-100,000
Closed -$8.11M – 209
2020
Q2 		$8.11M Buy
+100,000
New +$8.06M 1.21% 13

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Monashee Investment Management's GH Position: Q3 2023 in Review

Monashee Investment Management sold out of Guardant Health (GH) in Q3 2023, closing a stake of 37,000 shares — an estimated $1.32M sold.

Monashee Investment Management first reported a position in GH in Q2 2020 and held it in 4 quarters. The position peaked at $8.11M in Q2 2020. 296 funds tracked by Wall St. Rank hold GH as of Q3 2023.

  • Monashee Investment Management reported no remaining Guardant Health position as of Q3 2023 after selling out during the quarter.
  • Monashee Investment Management sold 37,000 Guardant Health shares in Q3 2023, an estimated $1.32M.
  • Monashee Investment Management first reported a position in Guardant Health in Q2 2020 and held it in 4 quarters.
  • Monashee Investment Management's Guardant Health position peaked at $8.11M in Q2 2020.
  • 296 funds tracked by Wall St. Rank held Guardant Health as of Q3 2023.

Based on Monashee Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.